Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marisa Rosso

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Investigational New Drugs|January 17, 2009
The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drugMiguel Muñoz, Marisa Rosso
Cancers|February 13, 2025
Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine GliomaMiguel Muñoz, Marisa Rosso
Current Drug Targets|January 14, 2011
The NK-1 receptor: a new target in cancer therapyMiguel Muñoz, Marisa Rosso, Rafael Coveñas
Thescientificworldjournal|May 1, 2012
The role of neurokinin-1 receptor in the microenvironment of inflammation and cancerMarisa Rosso, Miguel Muñoz, Michael Berger
Mini Reviews in Medicinal Chemistry|November 14, 2019
Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic ApproachMiguel Muñoz, Marisa Rosso, Rafael Coveñas
Pharmacological Reports : PR|May 28, 2017
The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell linesMiguel Muñoz, Marisa Rosso, Rafael Coveñas
Journal of Clinical Medicine|March 29, 2023
Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma PatientsPrema Robinson, Marisa Rosso, Miguel Muñoz
Cancers|August 31, 2019
Neurokinin-1 Receptor Antagonists against HepatoblastomaMiguel Muñoz, Marisa Rosso, Rafael Coveñas
Acta Histochemica|March 23, 2017
Increased nuclear localization of substance P in human gastric tumor cellsMiguel Muñoz, Marisa Rosso, Andrés Carranza, et al.
Cancers|November 28, 2013
The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell LinesMiguel Muñoz, Marisa Rosso, Ana González-Ortega, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Investigational New Drugs|January 17, 2009
The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drugMiguel Muñoz, Marisa Rosso
Cancers|February 13, 2025
Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine GliomaMiguel Muñoz, Marisa Rosso
Current Drug Targets|January 14, 2011
The NK-1 receptor: a new target in cancer therapyMiguel Muñoz, Marisa Rosso, Rafael Coveñas
Thescientificworldjournal|May 1, 2012
The role of neurokinin-1 receptor in the microenvironment of inflammation and cancerMarisa Rosso, Miguel Muñoz, Michael Berger
Mini Reviews in Medicinal Chemistry|November 14, 2019
Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic ApproachMiguel Muñoz, Marisa Rosso, Rafael Coveñas
Pharmacological Reports : PR|May 28, 2017
The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell linesMiguel Muñoz, Marisa Rosso, Rafael Coveñas
Journal of Clinical Medicine|March 29, 2023
Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma PatientsPrema Robinson, Marisa Rosso, Miguel Muñoz
Cancers|August 31, 2019
Neurokinin-1 Receptor Antagonists against HepatoblastomaMiguel Muñoz, Marisa Rosso, Rafael Coveñas
Acta Histochemica|March 23, 2017
Increased nuclear localization of substance P in human gastric tumor cellsMiguel Muñoz, Marisa Rosso, Andrés Carranza, et al.
Cancers|November 28, 2013
The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell LinesMiguel Muñoz, Marisa Rosso, Ana González-Ortega, et al.
Pageof 3